0
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found

      Luteinising Hormone-Releasing Hormone Analogues Alone in the Treatment of Advanced Disease

      Hormone Research in Paediatrics

      S. Karger AG

      Advanced prostate cancer, Monotherapy, Luteinising hormone-releasing hormone analogues

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In the treatment of advanced prostate cancer, luteinising hormone-releasing hormone analogue monotherapy is a valuable alternative to standard treatment such as oestrogen therapy or surgical castration. The basis for this is discussed and reference is made to posters presented at the International Symposium on Endocrine Therapy.

          Related collections

          Author and article information

          Journal
          HRE
          Horm Res Paediatr
          10.1159/issn.1663-2818
          Hormone Research in Paediatrics
          S. Karger AG
          978-3-8055-5105-2
          978-3-318-01977-3
          1663-2818
          1663-2826
          1989
          1989
          02 December 2008
          : 32
          : Suppl 1
          : 62-65
          Affiliations
          University Hospital, Nijmegen, The Netherlands
          Article
          181313 Horm Res 1989;32:62–65
          10.1159/000181313
          2533157
          © 1989 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 4
          Categories
          Prostate Cancer

          Comments

          Comment on this article